Zongpei Song

Title: Zongpei Song: Innovator in Biopharmaceuticals

Introduction

Zongpei Song is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative therapies targeting cancer.

Latest Patents

Zongpei Song holds 2 patents that showcase his expertise in creating advanced medical solutions. His latest patents include "Anti-BCMA single domain antibodies and application thereof," which describes a group of anti-BCMA single domain antibodies, their genes, and various applications for detection and treatment. These antibodies are characterized by high activity, stability, specificity, and binding capability. Another notable patent is "BCMA chimeric antigen receptor based on single domain antibody and use thereof," which details a chimeric antigen receptor (CAR) that includes a BCMA binding domain and various functional domains essential for its operation.

Career Highlights

Zongpei Song is currently associated with Shenzhen Pregene Biopharma Co. Ltd., where he continues to push the boundaries of biopharmaceutical research. His work focuses on developing therapies that leverage the unique properties of single domain antibodies.

Collaborations

Zongpei collaborates with talented individuals in his field, including Jishuai Zhang and Hongjian Li. Their combined expertise enhances the innovative capacity of their projects.

Conclusion

Zongpei Song's contributions to biopharmaceuticals through his patents and collaborations highlight his role as a leading inventor in the industry. His work continues to pave the way for advancements in cancer treatment.